SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-20-013749
Filing Date
2020-09-18
Accepted
2020-09-18 16:05:52
Documents
14
Period of Report
2020-09-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20200916.htm   iXBRL 8-K 40728
  Complete submission text file 0001628280-20-013749.txt   191380

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20200916.xsd EX-101.SCH 2421
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT arqt-20200916_cal.xml EX-101.CAL 712
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT arqt-20200916_def.xml EX-101.DEF 1649
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20200916_lab.xml EX-101.LAB 26303
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20200916_pre.xml EX-101.PRE 13733
7 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20200916_htm.xml XML 11658
Mailing Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361
Business Address 2945 TOWNSGATE ROAD SUITE 110 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 201184077
SIC: 2834 Pharmaceutical Preparations